Hyperinsulinemia and atherosclerosis

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Metabolic Disorders

Background:

• Non-insulin-dependent diabetes mellitus (NIDDM) is associated with a higher prevalence of macrovascular diseases, including peripheral vascular, coronary, and carotid artery disease, compared to non-diabetic individuals.
• The increased risk appears correlated with elevated insulin levels and hyperinsulinemia, a condition characterized by excess insulin in the blood.
• A cluster of metabolic abnormalities, termed Metabolic Syndrome or Syndrome X, including hyperinsulinemia, insulin resistance, hypertension, dyslipoproteinemia, and central obesity (high waist-hip ratio), is strongly linked to NIDDM and heightened macrovascular disease risk, often preceding NIDDM diagnosis.

Purpose of the Study:

• To highlight the significant association between NIDDM and macrovascular disease.
• To underscore the role of hyperinsulinemia and associated metabolic factors in this increased risk.
• To advocate for proactive screening and management strategies for cardiovascular risks in individuals with NIDDM and pre-diabetic states.

Main Methods:

• Review of existing studies on macrovascular disease prevalence in diabetic and non-diabetic populations.
• Analysis of the relationship between insulin levels, hyperinsulinemia, and macrovascular complications.
• Identification of key components of Metabolic Syndrome and their association with NIDDM and cardiovascular risk.

Main Results:

• Diabetics exhibit a significantly higher incidence of peripheral vascular, coronary, and carotid artery diseases.
• Hyperinsulinemia and insulin resistance are key factors contributing to macrovascular disease in NIDDM.
• Metabolic Syndrome components are prevalent in NIDDM and predict increased macrovascular risk, often existing before NIDDM diagnosis.

Conclusions:

• Preventing macrovascular disease in NIDDM likely requires addressing multiple factors due to the complexity of Metabolic Syndrome.
• Regular screening for cardiovascular risk parameters and early signs of macrovascular disease is recommended for patients with pre-NIDDM and overt NIDDM.
• Interventions aimed at reducing insulin resistance and hyperinsulinemia are suggested for preventing macrovascular disease in individuals with glucose intolerance.